Unlocking Opportunities in the Global Market for Blood Plasma Products
Apr 24,2023 | Healthcare Services
Plasma is a major component of the blood that plays an essential role in regulating bodily functions. It constitutes around 55% of the total volume of blood, and comprises more than 700 proteins and other substances. It is a major component used in the treatment of health problems such as haemophilia and autoimmune disorders. Improved diagnostic facilities and the prevalence of chronic diseases are major factors that have raised the demand for plasma-derived products.
The blood plasma products market is primarily segmented into five major categories: immunoglobulin, albumin, hyperimmune globulin, coagulation factor concentrates, and other plasma fractionation products.
If you're looking for a comprehensive business market study, Bharatbook has you covered by offering the latest analysis on the Global Markets for Blood Plasma Products. This research report presents an in-depth analysis of the global blood plasma products market by product type, application, end user and geographic market. In addition, it provides qualitative information related to the mode of delivery for blood plasma, key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing.
Immunology, oncology, pulmonology, rheumatology, transplant, neurology, hematology and other applications are explained in the report. Products based on these applications are explored in detail and their influence on R&D is examined. In the analysis based on end users, the blood plasma products market is segmented into the following: hospitals and clinics, research laboratories, academic institutions and blood transfusion centres.
In terms of geography, the study analyses the market across North America, Europe, Asia-Pacific and the Rest of the World (RoW). Key regions like the U.S., Canada, Europe (U.K., Italy, France, Germany), China, India, Australia and Japan are highlighted in the discussion due to a high concentration of blood plasma products manufacturing companies and contract manufacturing organizations in these areas. This report includes estimates of market size using 2021 as the base year and forecasting forward to 2027. Recent products launched by blood plasma products companies are studied and listed in the report. The estimated values that are used are based on the manufacturers’ total revenues.
Furthermore, a detailed analysis illustrating market dynamics and market structure is incorporated in the report. The market’s supply and distribution chain are discussed in detail in order to provide an in-depth understanding of the market. It also features top market players, along with details about their individual business operations and segment focus as well as analyses about their revenue and strategies, and it surveys patents that highlight past, current and projected global technology trends. In addition, market share analysis of leading market players, product launches and pipeline products are provided.
Some of the major players in the industry include ADMA Biologics Inc., China Biologic Products Inc., Kedrion SpA, Octapharma AG, and Takeda Pharmaceutical Co. Ltd.
To explore the market in more detail, please visit Global Markets for Blood Plasma Products
